Aldeyra The (ALDX) vs Apollomics, Inc. (APLM)
A side-by-side comparison of Aldeyra The and Apollomics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALDX
Aldeyra The
$0.93HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
APLM
Apollomics, Inc.
$22.38HealthcareDelayed quote: Oct 6, 2026, 11:03 AM EDT
Total return — ALDX vs APLM
growth of $100 · dividends reinvested · last 5yALDX -88.4% (-35.0%/yr)APLM -97.6% (-52.8%/yr)ALDX compounded faster over this window
ALDX APLM
ALDX vs APLM: by the numbers
- •ALDX is the larger company ($56M vs $49M market cap).
- •Both run net losses; ALDX's is the smaller (0.00% vs -128.69% net margin).
Metrics side by side
Valuation
| Metric | ALDX | APLM |
|---|---|---|
| P/B ratio | 1.48 | N/A |
Profitability
| Metric | ALDX | APLM |
|---|---|---|
| Gross margin | 0.00% | 97.00% |
| Operating margin | 0.00% | -111.45% |
| Net margin | 0.00% | -128.69% |
| ROE | -60.85% | N/A |
| ROIC | -63.52% | -2441.49% |
Growth (annualized)
| Metric | ALDX | APLM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 35.84% |
| Total return CAGR (5Y) | -36.54% | N/A |
Go deeper
Dig into the metrics
Aldeyra The ROEApollomics ROEAldeyra The operating marginApollomics operating marginAldeyra The revenue growthApollomics revenue growthAldeyra The free cash flowApollomics free cash flow
Aldeyra The & Apollomics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.